D-0296-2021 Class II Terminated

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0296-2021 was initiated by Noven Pharmaceuticals Inc on Feb 19, 2021 and is designated Class II. Reason for recall: Defective Delivery System: Out of specification for mechanical peel. The recall status is terminated (terminated Jul 5, 2024). Affected quantity: 934,140 patches.

Recall details

Product Type
Drugs
Report Date
Mar 10, 2021
Initiation Date
Feb 19, 2021
Termination Date
Jul 5, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
934,140 patches

Product description

Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5555-3.

Reason for recall

Defective Delivery System: Out of specification for mechanical peel.

Distribution pattern

Nationwide in the USA

Code information

Lots #: 87377, Exp 3/2021, 87572, Exp 3/2021, 87581, Exp 4/2021, 87820, Exp 5/2021, 88246, Exp 6/2021, 88535, Exp 7/2021, 88536, Exp 8/2021, 88537, Exp 8/2021 & 88939, Exp 8/2021.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0296-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0296-2021. Report a data issue: hello@regdatalab.com.